Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD)

Recruitment of patients with idiopathic and different forms of monogenic PD, as well as healthy controls, took place at the Institute of Neurogenetics at the University of Lübeck (UL) and the Department of Neurology at the University College London (UCL). Large-scale blood based targeted metabolomics analyses of 304 metabolites covering acylcarnitines, amines, organic acids, lipids and signaling lipids were performed in 140 idiopathic and 19 monogenic PD patients and 64 controls.

For requesting access to the data, please fill out and sign the Data Access Agreement document and send it to the SysMedPD Metabolomics Data Access Committee (christine_klein@uni-luebeck.de).

Clinical characteristics of Parkinson's Disease patients and healthy controls

Targeted metabolomics data from blood samples using five different platforms (amines, acylcarnitines, organic acids, signaling lipids and lididomics)